Ortho Clinical Diagnostics Holdings plc Overview

Ortho Clinical Diagnostics Holdings plc Research & Development

Research & Development expenses for OCDX.

Quarterly R&D Expenses

$32.20M

↑ 11.42% YoY

As of Apr 3, 2022

Annual R&D Expenses (TTM)

$129.50M

↑ 9.56% YoY

Trailing 12 months ending Apr 3, 2022

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin